Eiko Lifesciences Ltd vs Jubilant Ingrevia Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Eiko Lifesciences Ltd is ₹ 52.4 as of 20 Mar 15:30 . The P/E Ratio of Eiko Lifesciences Ltd changed from 31.1 on March 2025 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Jubilant Ingrevia Ltd changed from 40.9 on March 2025 to 39 on March 2024 . This represents a CAGR of -0.95% over 5 years The Market Cap of Eiko Lifesciences Ltd changed from ₹ 65.15 crore on March 2025 to ₹ 0 crore on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Jubilant Ingrevia Ltd changed from ₹ 10350 crore on March 2025 to ₹ 7194 crore on March 2024 . This represents a CAGR of -7.02% over 5 years The revenue of Eiko Lifesciences Ltd for the Dec '25 is ₹ 12.33 crore as compare to the Sep '25 revenue of ₹ 11.97 crore. This represent the growth of 3.01% The revenue of Jubilant Ingrevia Ltd for the Dec '25 is ₹ 1060 crore as compare to the Sep '25 revenue of ₹ 1131 crore. This represent the decline of -6.29% The ebitda of Eiko Lifesciences Ltd for the Dec '25 is ₹ 2.22 crore as compare to the Sep '25 ebitda of ₹ 2.07 crore. This represent the growth of 7.25% The ebitda of Jubilant Ingrevia Ltd for the Dec '25 is ₹ 122.91 crore as compare to the Sep '25 ebitda of ₹ 146.25 crore. This represent the decline of -15.96% The net profit of Eiko Lifesciences Ltd changed from ₹ 0.35 crore to ₹ 1.43 crore over 7 quarters. This represents a CAGR of 123.51% The net profit of Jubilant Ingrevia Ltd changed from ₹ 48.74 crore to ₹ 46.9 crore over 7 quarters. This represents a CAGR of -2.17% The Dividend Payout of Eiko Lifesciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Jubilant Ingrevia Ltd changed from 14.45 % on March 2021 to 30.24 % on March 2025 . This represents a CAGR of 15.92% over 5 years .

About Eiko Lifesciences Ltd

Eiko Lifesciences Limited was originally incorporated on January 07, 1977, under the name Narendra Investments (Delhi) Limited.
Later, the Company changed its name from Narendra Investments (Delhi) Limited to Eiko LifeSciences Limited effective from June 24, 2021.
Earlier, the Company engaged in sale and purchase of shares and securities.
At present, the Company is a leading manufacturer, supplier and exporter of Speciality Chemicals and Pharma Intermediates in India and globally. The Company commenced new business activity primarily in manufacturing of speciality and fine chemicals in October, 2020 from manufacturing facility located at Badlapur, Maharashtra and has since scaled its operations, grown brand and customer base to become the one of the fastest growing speciality chemicals companies in India.

About Jubilant Ingrevia Ltd

Jubilant Ingrevia Limited (Formerly known as Jubilant LSI Limited) was incorporated as a Public Limited Company on October 23, 2019 in Uttar Pradesh.
The name of the Company was changed from 'Jubilant LSI Limited' to 'Jubilant Ingrevia Limited' on October 16, 2020. The Company is a global integrated Life Science products and Innovative Solutions provider serving Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards.
The Company is a part of the Jubilant Bhartia Group, a diversified global conglomerate founded by Mr. Shyam S. Bhartia and Mr. Hari S. Bhartia. Today, the Group has a strong presence in diverse sectors like Pharmaceuticals, Contract Research and Development Services, Proprietary Novel Drugs, Life Science Ingredients, Agri Products, Performance Polymers, Food Service (QSR), Food, Auto, Consulting in Aerospace and Oilfield Services.

FAQs for the comparison of Eiko Lifesciences Ltd and Jubilant Ingrevia Ltd

Which company has a larger market capitalization, Eiko Lifesciences Ltd or Jubilant Ingrevia Ltd?

Market cap of Eiko Lifesciences Ltd is 75 Cr while Market cap of Jubilant Ingrevia Ltd is 9,313 Cr

What are the key factors driving the stock performance of Eiko Lifesciences Ltd and Jubilant Ingrevia Ltd?

The stock performance of Eiko Lifesciences Ltd and Jubilant Ingrevia Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Eiko Lifesciences Ltd and Jubilant Ingrevia Ltd?

As of March 23, 2026, the Eiko Lifesciences Ltd stock price is INR ₹52.4. On the other hand, Jubilant Ingrevia Ltd stock price is INR ₹584.7.

How do dividend payouts of Eiko Lifesciences Ltd and Jubilant Ingrevia Ltd compare?

To compare the dividend payouts of Eiko Lifesciences Ltd and Jubilant Ingrevia Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.